Nmda receptors in health and diseases: new roles and signaling pathways—anti-n-methyl-d-aspartate receptor (nmdar) autoantibodies as potential biomarkers of fatigue in patients with rheumatic diseases

HIGHLIGHTS

• who: Tatjana Marinoska and collaborators from the Center for Rheumatic Disease Rhineland-Palatinate, Bad Kreuznach, Germany Division of Rheumatology and Clinical Immunology, University Medical Center of the Johannes Gutenberg have published the research work: NMDA Receptors in Health and Diseases: New Roles and Signaling Pathwaysu2014Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic Diseases, in the Journal: (JOURNAL) of 27/07/2022
• what: The authors examined whether this association also applies to patients with other rheumatic diseases. The authors report that circulating anti-NR2 antibodies are not . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.